Enbrel 50 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FXUY5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,941
Award facts
- Contract value 100% obligated
- $14,940.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,940.94 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes on January 22, 2026. This non-competitive delivery order, classified as firm fixed-price, was issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle that runs through December 2026. The product will be supplied from the awardee's location in Conshohocken, Pennsylvania, with a completion date of January 23, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems.
AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical serves as a comprehensive vehicle for supplying an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's demonstrated capability to efficiently fulfill government pharmaceutical requirements through open competition, as reflected in its substantial contract portfolio with the Defense Logistics Agency and other federal agencies, positions it as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FXUY5?
SPE2DR26FXUY5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FXUY5 worth?
The government has obligated $14,941 on SPE2DR26FXUY5.
Is contract SPE2DR26FXUY5 an order under another contract?
Yes. SPE2DR26FXUY5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUY5 competed?
The extent of competition for SPE2DR26FXUY5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award